Accessibility Statement

Equulus Therapeutics Inc. is committed to ensuring digital accessibility for all visitors, including people with disabilities. We are continually improving the user experience of our website to make it accessible, usable, and inclusive for everyone.

1. Our Commitment

We aim to follow accessibility standards and guidelines, including the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA, which outline best practices for creating accessible digital content.

2. Measures We Take

To support accessibility, Equulus:

Designs and develops content with accessibility in mind.
Uses alt text for images and descriptive links.
Ensures proper color contrast and text readability.
Provides keyboard navigation support.
Tests our site regularly for accessibility issues.

3. Ongoing Efforts

Accessibility is an ongoing effort. We regularly review our site and update content, features, and technology to maintain and improve accessibility standards.

4. Third-Party Content

While we strive to ensure accessibility across our site, some third-party content or links may not fully comply with accessibility standards. We cannot control the accessibility of content provided by external websites or services.

5. Feedback

We welcome your feedback on the accessibility of our website. If you encounter barriers or have suggestions for improvement, please contact us:

Equulus Therapeutics Inc.

8041 Briar Creek Parkway, Suite 1072,

Raleigh, NC 27617
info@equulus.com

We aim to respond to accessibility feedback within 5 business days and work toward a solution.

6. Date of Statement

This Accessibility Statement was last updated on October 1, 2025.